BlackRock Institutional Trust’s Opus Genetics IRD Stock Holding History

BlackRock Institutional Trust’s Portfolio IRD Stock Details IRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$47K	Hold	697	–	–	﹤0.01%	3715
2016 Q3	$70K	Hold	697	–	–	﹤0.01%	3725
2016 Q2	$84K	Hold	697	–	–	﹤0.01%	3730
2016 Q1	$110K	Hold	697	–	–	﹤0.01%	3700
2015 Q4	$121K	Hold	697	–	–	﹤0.01%	3727
2015 Q3	$174K	Hold	697	–	–	﹤0.01%	3657
2015 Q2	$203K	Hold	697	–	–	﹤0.01%	3633
2015 Q1	$244K	Buy	697 +591	+558%	+$215K	﹤0.01%	3615
2014 Q4	$35K	Buy	+106	New	+$36.6K	﹤0.01%	3799
2014 Q2	–	Sell	-65	Closed	-$34K	–	4048
2014 Q1	$34K	Buy	+65	New	+$35.2K	﹤0.01%	3849

Other funds holding IRD

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HVIA

Hudson Valley Investment Advisors Goshen, New York $772M AUM 25.84% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BMC

Benin Management Corp Wilton, Connecticut $494M AUM 25.95% 1-Year Est. Return

BlackRock Institutional Trust's IRD Position: Q4 2016 in Review

BlackRock Institutional Trust held its Opus Genetics (IRD) position steady in Q4 2016 at 697 shares worth $47K. The position accounts for ﹤0.01% of the portfolio, ranked #3715.

BlackRock Institutional Trust first reported a position in IRD in Q1 2014 and has held it in 10 quarters since. The position peaked at $244K in Q1 2015. 31 funds tracked by Wall St. Rank hold IRD as of Q4 2016.

BlackRock Institutional Trust held 697 shares of Opus Genetics worth $47K as of Q4 2016.
BlackRock Institutional Trust left its Opus Genetics share count unchanged in Q4 2016.
Opus Genetics made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3715 holding.
BlackRock Institutional Trust first reported a position in Opus Genetics in Q1 2014 and has held it in 10 quarters since.
BlackRock Institutional Trust's Opus Genetics position peaked at $244K in Q1 2015.
31 funds tracked by Wall St. Rank held Opus Genetics as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.